Menarini, the leading Italian pharmaceutical group, has opened its regional headquarters in Dubai Science Park as part of its goal to expand its presence to the Middle East and Africa (MEA) region.
Menarini Middle East and Africa, the Group’s new regional office specializing in pharmaceutical research and production, consumer healthcare, oncology, and diagnostics, acts as an ideal hub location to elevate patient health and wellbeing in the region and form pivotal connections with key industry stakeholders.
The inauguration drew the participation of influential healthcare dignitaries, most notably H.E. Dr. Amin Hussain Al Amiri, Assistant Undersecretary of Public Health Policy and Licensing at the UAE Ministry of Health and Prevention, H.E. Nicola Lener, Ambassador of Italy to the UAE, as well as high-level executives from Menarini’s global team, as Dr. Luca Lastrucci, Group General Manager, Dr. Ugur Bingol META President and Dr. Basel Thaher Middle East Regional Head and MEA General Manager.
Luca Lastrucci Group GM Menarini
“Today’s inauguration of our MEA headquarters in Dubai is a significant milestone for our company as we expand our investments in the MEA region. Our presence in a leading pharmaceutical hub like Dubai will strengthen Menarini’s capabilities and improve market access in delivering breakthrough products in the areas of cardiovascular, gastrointestinal, and inflammatory diseases. The UAE government has shown unwavering support for pharmaco-economic investments through its solid commercial infrastructure and impressive facilities. We see this as a vital step in the right direction for Menarini and will continue to work side-by-side with the UAE government to raise healthcare standards and support the wellbeing of communities across the UAE and beyond.”
The new Menarini regional headquarters in Dubai will be led by Menarini it’s deeply rooted values of being patient-focused, people-centered, and committed to quality, integrity, and responsibility, which are present in 140 countries and employ over 17,000 people. This important milestone serves as a testament to Menarini’s ongoing mission of curing diseases on a global scale and prioritizing patient health above all else.
Dr. Ali Al Sayed, Director of the Pharmaceutical Services Department at the Dubai Health Authority, said that “A defining objective of Dubai’s 2030 strategy is to be a global hub for knowledge-based, sustainable and innovation focused businesses. As Menarini is a company with longstanding roots based in medical research, it will be a strong contributor to this visionary strategy. Together, we share Dubai’s overarching healthcare vision of positioning Dubai as the leading destination for healthcare knowledge, education and training.”
